BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 3246214)

  • 1. Sobrerol: New Perspectives to Manage Patients with Frequent Respiratory Infections.
    Ciprandi G; Varriccchio A
    Children (Basel); 2023 Jul; 10(7):. PubMed ID: 37508708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of erdosteine on cyclosporine induced chronic nephrotoxicity.
    Briguori C; Condorelli G
    Nephrourol Mon; 2012; 4(2):487-8. PubMed ID: 23573474
    [No Abstract]   [Full Text] [Related]  

  • 3. Erdosteine therapy for renal failure: current perspectives.
    Muthuraman A
    Nephrourol Mon; 2012; 4(3):587-8. PubMed ID: 23573492
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of erdosteine on sputum biochemical and rheologic properties: pharmacokinetics in chronic obstructive lung disease.
    Marchioni CF; Moretti M; Muratori M; Casadei MC; Guerzoni P; Scuri R; Fregnan GB
    Lung; 1990; 168(5):285-93. PubMed ID: 2126836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nesosteine: a new mucoregulatory agent.
    Scuri R; Mondani P; Frova C; Fantini L
    Drugs Exp Clin Res; 1986; 12(8):663-70. PubMed ID: 3757762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-(2,3-Dihydro-5-acetoxy-4,6,7-tribenzofuranyl)acetic acid (IRFI 016): a new antioxidant mucoactive drug.
    Scuri R; Giannetti P; Paesano A
    Drugs Exp Clin Res; 1990; 16(12):649-56. PubMed ID: 2130008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erdosteine enhances mucociliary clearance in rats with and without airway inflammation.
    Hosoe H; Kaise T; Ohmori K
    J Pharmacol Toxicol Methods; 1998 Oct; 40(3):165-71. PubMed ID: 10334633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucolytic and antitussive effects of erdosteine.
    Hosoe H; Kaise T; Ohmori K; Isohama Y; Kai H; Takahama K; Miyata T
    J Pharm Pharmacol; 1999 Aug; 51(8):959-66. PubMed ID: 10504037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of erdosteine and its metabolites on bacterial adhesiveness.
    Braga PC; Dal Sasso M; Sala MT; Gianelle V
    Arzneimittelforschung; 1999 Apr; 49(4):344-50. PubMed ID: 10337454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of erdosteine and its metabolites on tracheobronchial mucus production and transport.
    Scuri R; Giannetti P; Paesano A
    Drugs Exp Clin Res; 1988; 14(11):693-8. PubMed ID: 3246214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erdosteine.
    Dechant KL; Noble S
    Drugs; 1996 Dec; 52(6):875-81; discussion 882. PubMed ID: 8957158
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.